Who Paid My Doc
Bryan Seely
Physician Assistant, Surgical New Orleans, LA Physician Assistant
NPI 1568661437 CMS profile 10473836
1430 Tulane Ave, Ste 8632, New Orleans, LA 70112
General payments
$3,842
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Bryan Seely of New Orleans, LA is reported in the CMS Open Payments database as having received $3,842 across 84 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 93rd percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $552 | 14 | |
| 2024 | General | $110 | 4 | |
| 2023 | General | $429 | 19 | |
| 2022 | General | $1,325 | 23 | |
| 2021 | General | $1,426 | 24 |
Beside peers
- Bryan Seely
- Physician Assistant, Surgical median
- Middle half of Physician Assistant, Surgical
- National median
In program year 2025, general payments to Bryan Seely were reported at $552. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.
Show as a table
| Year | Bryan Seely | Physician Assistant, Surgical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $1,426 | $111 | $36–$285 | $132 |
| 2022 | $1,325 | $126 | $44–$350 | $149 |
| 2023 | $429 | $137 | $47–$355 | $160 |
| 2024 | $110 | $146 | $49–$384 | $164 |
| 2025 | $552 | $146 | $51–$385 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
428
Drug cost
$4,294
Branded share of claims
10.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gabapentin | Generic | 102 | $1,019 | |
| Cyclobenzaprine Hcl | Generic | 69 | $811 | |
| Celecoxib | Generic | 36 | $436 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 33 | $355 | |
| Duloxetine Hcl | Generic | 19 | $336 | |
| Ondansetron Hcl | Generic | 35 | $306 | |
| Memantine Hcl | Generic | 20 | $290 | |
| Pregabalin | Generic | 32 | $279 | |
| Mupirocin | Generic | 30 | $206 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 13 | $105 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 26 billing codesPaid by Medicare
$10,278
Medicare patients
86
Services billed
438
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 73% | |
| Diabetes | 30% | |
| Ischemic heart disease | 26% | |
| Chronic kidney disease | 22% | |
| Depression | 22% | |
| Osteoporosis | 20% | |
| Cancer | 19% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
84 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Physician Assistant, Surgical in Louisiana
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Surgical
Everyone recorded under this specialty, nationwide.
Doctors in Louisiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.